Yuling L. Nie
No. 91, Tianchi Road, Uygur Autonomous Region
Ueruemqi, 830001, China
Ueruemqi, 830001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis.
Journal: Clinical and experimental medicine
Published: October 21, 2022
Distribution and prognostic value of LymphGen genotyping in patients with diffuse large B-cell lymphoma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: June 09, 2022
CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
Journal: Biomarkers in medicine
Published: May 27, 2021
miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Journal: Molecular and cellular probes
Published: March 13, 2019
Correlation analysis between JAK2, MPL, and CALR mutations in patients with myeloproliferative neoplasms of Chinese Uygur and Han nationality and their clinical characteristics.
Journal: The Journal of international medical research
Published: August 08, 2018
The interaction between ATRIP and MCM complex is essential for ATRIP chromatin loading and its phosphorylation in mantle cell lymphoma cells.
Journal: Die Pharmazie
Published: February 15, 2018
MiR-148a participates in the growth of RPMI8226 multiple myeloma cells by regulating CDKN1B.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 18, 2016
Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression.
Journal: International journal of hematology
Published: August 05, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026